FDA Drug Application (200678) for KOMBIGLYZE XR by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number200678
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG;EQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKOMBIGLYZE XR
Active IngredientMETFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32
List of drugs with Active Ingredient SAXAGLIPTIN HYDROCHLORIDE2


Back to FDA Applications sponsored by ASTRAZENECA AB